BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17554803)

  • 1. Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting.
    Pennings JL; Siljee JE; Imholz S; Kuc S; de Vries A; Schielen PC; Rodenburg W
    Dis Markers; 2014; 2014():509821. PubMed ID: 25132703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chorionic gonadotropin beta-gene variants are associated with recurrent miscarriage in two European populations.
    Rull K; Nagirnaja L; Ulander VM; Kelgo P; Margus T; Kaare M; Aittomäki K; Laan M
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4697-706. PubMed ID: 18782867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Savine in the Treatment of Habitual Abortion.
    Metsch
    West J Med Surg; 1851 Mar; 7(3):246-247. PubMed ID: 38209903
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy.
    Ziolkowska K; Dydowicz P; Sobkowski M; Tobola-Wrobel K; Wysocka E; Pietryga M
    Ginekol Pol; 2019; 90(3):161-166. PubMed ID: 30950006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value.
    Tóth E; Györffy D; Posta M; Hupuczi P; Balogh A; Szalai G; Orosz G; Orosz L; Szilágyi A; Oravecz O; Veress L; Nagy S; Török O; Murthi P; Erez O; Papp Z; Ács N; Than NG
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A summary analysis of Down syndrome markers in the late first trimester.
    Palomaki GE; Lambert-Messerlian GM; Canick JA
    Adv Clin Chem; 2007; 43():177-210. PubMed ID: 17249384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum free beta-hCG and PAPP-A in patients with habitual abortion-influence on first-trimester screening for chromosomal abnormalities.
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Sep; 27(9):814-6. PubMed ID: 17554803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of maternal systemic lupus erythematosus on first-trimester combined screening for chromosomal abnormalities.
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Jul; 27(7):600-2. PubMed ID: 17437322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does vaginal bleeding influence first-trimester markers for Down syndrome?
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Witteler R; Mosel A; Ahrens A; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.